ResearcherCold Spring Harbor LaboratoryActive in the last 2 years
Diogo Maia-Silva
Matched on ORCID iD 0000-0003-4910-9093; OpenAlex author ID A5019750561. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 6
- KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. Co-author DOI 10.1038/s41467-025-66007-0↗
- Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41588-024-01790-y↗
- p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2023.04.20.537667↗
- ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer. Co-author DOI 10.1073/pnas.1921484117↗
- Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. Co-author DOI 10.7554/elife.53381↗
- TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.celrep.2018.10.051↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christopher R. Vakoc · 6 shared papers, 2018–2025 · strength 0.91
- Paper KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. DOI 10.1038/s41467-025-66007-0↗
- Paper p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma DOI 10.1101/2023.04.20.537667↗
- Paper Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-024-01790-y↗
- Mikala Egeblad · 3 shared papers, 2020–2025 · strength 0.52
- Paper KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. DOI 10.1038/s41467-025-66007-0↗
- Paper Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma. DOI 10.1038/s41588-024-01790-y↗
- Paper Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. DOI 10.7554/elife.53381↗
- Tim D.D. Somerville · 4 shared papers, 2018–2023 · strength 0.48
- Paper p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma DOI 10.1101/2023.04.20.537667↗
- Paper ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer. DOI 10.1073/pnas.1921484117↗
- Paper Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. DOI 10.7554/elife.53381↗
- Damianos S. Skopelitis · 2 shared papers, 2024–2025 · strength 0.43
- Patrick Cunniff · 2 shared papers, 2024–2025 · strength 0.43
- Stella K. Hur · 3 shared papers, 2020–2023 · strength 0.40
- Paper p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma DOI 10.1101/2023.04.20.537667↗
- Paper ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer. DOI 10.1073/pnas.1921484117↗
- Paper Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. DOI 10.7554/elife.53381↗
- David Arthur Tuveson · 3 shared papers, 2018–2023 · strength 0.37
- Paper p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma DOI 10.1101/2023.04.20.537667↗
- Paper Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. DOI 10.7554/elife.53381↗
- Paper TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.celrep.2018.10.051↗
- Nicole Sivetz · 1 shared paper, 2025 · strength 0.27
- Faiyaz Notta · 1 shared paper, 2023 · strength 0.19
- Koji Miyabayashi · 2 shared papers, 2018–2020 · strength 0.17
- Camila dos Santos · 1 shared paper, 2024 · strength 0.16
- David L Spector · 1 shared paper, 2024 · strength 0.16
- Ledong Wan · 1 shared paper, 2024 · strength 0.16
- Yunus Sahin · 1 shared paper, 2024 · strength 0.16
- Douglas T. Fearon · 1 shared paper, 2024 · strength 0.16
- Philip Moresco · 1 shared paper, 2024 · strength 0.16
- Adrian R. Krainer · 1 shared paper, 2024 · strength 0.16
- Michael Anthony Hollingsworth · 1 shared paper, 2020 · strength 0.09
- Giulia Biffi · 1 shared paper, 2020 · strength 0.09
- Hervé Tiriac · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.